Conference
Phase II Dose-Finding Study with TAK-442, An Oral Factor Xa Inhibitor, in Patients Undergoing Elective Knee Arthroplasty.
Authors
Weit JI; Cao C; Eriksson B; Fisher WD; Kupfer S; Raskob GE; Spaeder J; Turpie AGG
Volume
114
Pagination
pp. 76-76
Publisher
AMER SOC HEMATOLOGY
Publication Date
November 20, 2009
Name of conference
51st Annual Meeting of the American-Society-of-Hematology
Conference place
New Orleans, LA
Conference start date
December 5, 2009
Conference end date
December 8, 2009
Conference proceedings
BLOOD
Issue
22
ISSN
0006-4971